Strata Critical Medical (SRTA) Stock Statistics & Valuation Metrics

Strata Critical Medical has a market cap or net worth of $464.65M. The enterprise value is $425.10M.

Strata Critical Medical has 86,526,570 shares outstanding. The number of shares has decreased by -2.65% in one year.

Strata Critical Medical’s return on equity (ROE) is 0.15 and return on invested capital (ROIC) is -7.30%.

The current PE Ratio of Strata Critical Medical is 35.7. Strata Critical Medical’s PEG ratio is -0.21.

In the last 12 months, Strata Critical Medical had revenue of 197.14M and earned 41.35M in profits. Earnings per share was -0.19.

In the last 12 months, operating cash flow was -40.81M and capital expenditures -13.18M, giving a free cash flow of -53.99M billion.

Strata Critical Medical pays an annual dividend of ―, resulting in a dividend yield of ―

Strata Critical Medical upcoming earnings date is Aug 11, 2026, After Close (Confirmed).

Strata Critical Medical as a current ratio of 6.38, with Debt / Equity ratio of 1.56%

In the past 12 months, Strata Critical Medical has paid 0.00 in taxes.

Strata Critical Medical EV to EBITDA ratio is -26.04, with an EV/FCF ratio of -6.16.

Strata Critical Medical has $58.79M in cash and marketable securities with $4.47M in debt, giving a net cash position of $54.32M billion.

Gross margin is 21.10%, with operating margin of -11.34%, and net profit margin of 20.97%.

The average price target for Strata Critical Medical is $9.17, which is 11.43% higher than the current price. The consensus rating is Strong Buy